• search hit 4 of 18
Back to Result List

The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression

Please always quote using this URN: urn:nbn:de:bvb:20-opus-235064
  • The transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses the activity of the melanocyte lineage marker MITF in melanoma, thereby reducing the expression of pigmentation markers. Intriguingly, we furthermore identified NRF2 as key regulator of immune-modulating genes, linking oxidativeThe transcription factor NRF2 is the major mediator of oxidative stress responses and is closely connected to therapy resistance in tumors harboring activating mutations in the NRF2 pathway. In melanoma, such mutations are rare, and it is unclear to what extent melanomas rely on NRF2. Here we show that NRF2 suppresses the activity of the melanocyte lineage marker MITF in melanoma, thereby reducing the expression of pigmentation markers. Intriguingly, we furthermore identified NRF2 as key regulator of immune-modulating genes, linking oxidative stress with the induction of cyclooxygenase 2 (COX2) in an ATF4-dependent manner. COX2 is critical for the secretion of prostaglandin E2 and was strongly induced by H\(_2\)O\(_2\) or TNFα only in presence of NRF2. Induction of MITF and depletion of COX2 and PGE2 were also observed in NRF2-deleted melanoma cells in vivo. Furthermore, genes corresponding to the innate immune response such as RSAD2 and IFIH1 were strongly elevated in absence of NRF2 and coincided with immune evasion parameters in human melanoma datasets. Even in vitro, NRF2 activation or prostaglandin E2 supplementation blunted the induction of the innate immune response in melanoma cells. Transcriptome analyses from lung adenocarcinomas indicate that the observed link between NRF2 and the innate immune response is not restricted to melanoma.show moreshow less

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar Statistics
Metadaten
Author: Christina Jessen, Julia K. C. Kreß, Apoorva Baluapuri, Anita Hufnagel, Werner Schmitz, Susanne Kneitz, Sabine Roth, André Marquardt, Silke Appenzeller, Casten P. Ade, Valerie Glutsch, Marion Wobser, José Pedro Friedmann-Angeli, Laura Mosteo, Colin R. Goding, Bastian Schilling, Eva Geissinger, Elmar Wolf, Svenja Meierjohann
URN:urn:nbn:de:bvb:20-opus-235064
Document Type:Journal article
Faculties:Medizinische Fakultät / Physiologisches Institut
Medizinische Fakultät / Theodor-Boveri-Institut für Biowissenschaften
Medizinische Fakultät / Klinik und Poliklinik für Dermatologie, Venerologie und Allergologie
Medizinische Fakultät / Medizinische Klinik und Poliklinik II
Fakultät für Biologie / Rudolf-Virchow-Zentrum
Language:English
Parent Title (English):Oncogene
ISSN:0950-9232
Year of Completion:2020
Volume:39
Pagenumber:6841–6855
Source:Oncogene (2020) 39:6841–6855. https://doi.org/10.1038/s41388-020-01477-8
DOI:https://doi.org/10.1038/s41388-020-01477-8
Dewey Decimal Classification:5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 570 Biowissenschaften; Biologie
6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Tag:COX2 expression; NRF2; melanoma malignancy
Release Date:2021/06/11
Licence (German):License LogoCC BY: Creative-Commons-Lizenz: Namensnennung 4.0 International